Skip to main content

Clindamycin Phosphate Injection Shortage

Last Updated: July 1, 2025
Status: Current

Products Affected - Description
    • Cleocin injection, Pfizer, 150 mg/mL, 2 mL vial, 25 count, NDC 00009-0870-26
    • Cleocin injection, Pfizer, 150 mg/mL, 4 mL vial, 25 count, NDC 00009-0775-26
    • Cleocin injection, Pfizer, 150 mg/mL, 6 mL vial, 25 count, NDC 00009-0902-18
    • Cleocin injection, Pfizer, 150 mg/mL, 60 mL bulk vial, 5 count, NDC 00009-0728-09
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 60 mL bulk vial, 1 count, NDC 25021-0115-51
Reason for the Shortage
    • Almaject discontinued clindamycin injection in 2023.
    • Baxter has clindamycin injection available.
    • Hikma has clindamycin injection available.
    • Pfizer has clindamycin injection on shortage due to manufacturing delays.
    • Sagent has clindamycin injection on shortage due to increased demand.
    • Sandoz has clindamycin injection available.
Available Products
    • Clindamycin phosphate injection, Baxter, 300 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9545-24
    • Clindamycin phosphate injection, Baxter, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3410-24
    • Clindamycin phosphate injection, Baxter, 600 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9549-24
    • Clindamycin phosphate injection, Baxter, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3612-24
    • Clindamycin phosphate injection, Baxter, 900 mg/50 mL, in 0.9% sodium chloride premixed container, 24 count, NDC 00338-9553-24
    • Clindamycin phosphate injection, Baxter, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00338-3814-24
    • Clindamycin phosphate injection, Hikma, 300 mg/50 mL, in 5% dextrose premixed container, 60 count, NDC 00143-9267-01
    • Clindamycin phosphate injection, Hikma, 600 mg/50 mL, in 5% dextrose premixed container, 60 count, NDC 00143-9268-01
    • Clindamycin phosphate injection, Hikma, 900 mg/50 mL, in 5% dextrose premixed container, 60 count, NDC 00143-9269-01
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 2 mL vial, 25 count, NDC 25021-0115-02
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 4 mL vial, 25 count, NDC 25021-0115-04
    • Clindamycin phosphate injection, Sagent, 150 mg/mL, 6 mL vial, 25 count, NDC 25021-0115-06
    • Clindamycin phosphate injection, Sandoz, 300 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3288-09
    • Clindamycin phosphate injection, Sandoz, 600 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3289-09
    • Clindamycin phosphate injection, Sandoz, 900 mg/50 mL, in 5% dextrose premixed container, 24 count, NDC 00781-3290-09

Estimated Resupply Dates

    • Sagent has clindamycin phosphate 150 mg/mL 60 mL vials on back order and the company cannot estimate a release date.
    • Pfizer has Cleocin 150 mg/mL 2 mL, 4 mL, 6 mL, and 60 mL vials on back order and the company estimates a release date of July 2025 for the 2 mL, 6 mL, and 60 mL vials and August 2025 for the 4 mL vials.

Updated

Updated July 1, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 13, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer